Article information
Resumen
Aunque en la mayoría de las ocasiones la psoriasis presenta una clínica fundamentalmente cutánea, hoy sabemos que puede asociarse a otras enfermedades extracutáneas, tanto articulares como digestivas, metabólicas, cardiovasculares e incluso psíquicas.
Revisamos en este artículo las bases etiopatogénicas y los riesgos que los pacientes psoriásicos tienen para padecer estas llamadas comorbilidades.
Palabras clave:
Psoriasis
Comorbilidades
Abstract
Although in most majority the psoriasis presents/displays a clinical cutaneous today fundamentally we know that it can be associated to other diseases extracutaneous, as much you will articular, digestive, metabolic, cardiovascular and even psychic.
We reviewed in this article the atiopathogenics bases and the risks that the psoriáasics patients must to suffer these comorbidities.
Keywords:
Psoriasis
Comorbility
Full text is only aviable in PDF
Bibliografía
[1.]
L. Puig-Sanz.
La psoriasis ¿una enfermedad sistémica?.
Actas Dermosifiliogr, 98 (2007), pp. 396-402
[2.]
J. Koo.
Current consensus an update on psoriasis theraphy: a perspective from the US.
J Dermatol, 26 (1999), pp. 723-733
[3.]
C. Ferrándiz, X. Bordas, V. García-Patos, S. Puig, R. Pujol, A. Smadia.
Prevalence of psoriasis in Spain (Epiderma Project: Phase I).
J Eur Acad Dermatol Venereol, 15 (2001), pp. 20-23
[4.]
A.B. Gottlieb, C. Chao, F. Dann.
Psoriasis comorbidities.
J Dermatolog Treat, 19 (2008), pp. 5-21
[5.]
M.A. Cimmino.
Epidemiology of psoriasis and psoriatic arthritis.
Reumatismo, 59 (2007), pp. 19-24
[6.]
P. Gisondi, G. Girolomoni, F. Sampogna, S. Taboli, D. Abeni.
Prevalence of psoriatic artritis and joint complaints in a large population of Italian patients hospitalised for psoriasis.
Eur J Dermatol, 15 (2005), pp. 279-283
[8.]
P.J. Healy, C. Groves, M. Chandramohan, P.S. Helliwell.
MRI changes in psoriatic dactylitis-extent of pathology, relationship to tenderness and correlation with clinical indices.
Rheumatology (Oxford), 47 (2008), pp. 92-95
[9.]
S. Friedman, R.A. Blumberg.
Inflammatory bowel disease.
Harrison's principles of internal medicine, pp. 1676-1686
[10.]
D.J. Najarian, A.B. Gottlieb.
Connections between psoriasis and Crohn's disease.
J Am Acad Dermatol, 48 (2003), pp. 805-821
[11.]
F. Lee, S. Bellardy, C. Francis.
Incresed occurrence of psoriasis in patients wit Crohn's disease and their relatives.
A J Gatroenterol, 85 (1990), pp. 962-963
[12.]
E. Christophers.
Comorbilities in psoriasis.
J Eur Acad Dermatol Venereol, 20 (2006), pp. 52-55
[13.]
D. Margolis, W. Bilker, S. Hennesy, C. Vittorio, J. Santabba, B.L. Strom.
The risk of malignancy associated with psoriasis.
Arch Dermatol, 137 (2001), pp. 778-783
[14.]
J.M. Gelfand, J. Berlin, A. Van Voorhees, D.J. Margolis.
Lymphoma rates are low but incresed in patients with psoriasis: results from a population-based cohort study in the United Kingdom.
Arch Dermatol, 139 (2003), pp. 1425-1429
[15.]
S.M. Grundy, H.B. Brewer Jr, J.I. Cleeman, S.C. Smith Jr, C. Lenfant, American Heart Association; National Heart, Lung, and Blood Institute.
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific singes related to definition.
Circulation, 109 (2004), pp. 433-438
[16.]
R.H. Eckel, S.M. Grundy, P.Z. Zimmet.
The metabolic syndrome.
Lancet, 365 (2005), pp. 1415-1428
[17.]
P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, R. Garg.
Metabolic syndrome: a comprehensive perspective based on interaction between obesity, diabetes and inflammation.
Circulation, 111 (2005), pp. 1448-1454
[18.]
P. Gisondi, G. Tessari, A. Conti, S. Piaserico, S. Schianchi, A. Peserico, et al.
Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
Br J Dermatol, 157 (2007), pp. 68-73
[19.]
A.D. Cohen, H. Gilutz, Y. Henkin, D. Zahger, J. Shapiro, D.Y. Bonneh, et al.
Psoriasis and the metabolic syndrome.
Acta Derm Venereol, 87 (2007), pp. 506-509
[20.]
J. Shapiro, A.D. Cohen, M. David, E. Hodak, G. Chodik, A. Viner, et al.
The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study.
J Am Acad Dermatol, 56 (2007), pp. 629-634
[21.]
G. Favato.
High incidence of smoking habit in psoriatic patients.
Am J Med, 121 (2008), pp. e17
[22.]
U. Mrowietz, J.T. Elder, J. Barker.
The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients.
Arch Dermatol Res, 298 (2006), pp. 309-319
[23.]
G. Krueger, J. Koo, M. Lebwohl, A. Menter, R.S. Stern, T. Rolstad.
The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey.
Arch Dermatol, 137 (2001), pp. 280-284
[24.]
G. Schmid-Ott, H.W. Kunsebeck, B. Jager, U. Sittig, N. Hofste, R. Ott, et al.
Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women.
Acta Derm Venereol, 85 (2005), pp. 27-32
[25.]
D.G. Fortune, C.J. Main, T.M. O'Sullivan, C.E. Griffiths.
Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
Br J Dermatol, 137 (1997), pp. 755-760
[26.]
M.A. Gupta, A.K. Gupta.
Psoriasis and sex: a study of moderately to severely affected patients.
Int J Dermatol, 36 (1997), pp. 259-262
[27.]
I.H. Ginsburg, B.G. Link.
Psychosocial consequences of rejection and stigma feelings in psoriasis patients.
Int J Dermatol, 32 (1993), pp. 587-591
[28.]
S.R. Rapp, S.R. Feldman, M.L. Exum, A.B. Fleischer Jr., D.M. Reboussin.
Psoriasis causes as much disability as other major medical diseases.
J Am Acad Dermatol, 41 (1999), pp. 401-407
[29.]
J. Choi, J.Y. Koo.
Quality of life issues in psoriasis.
J Am Acad Dermatol, 49 (2003), pp. 57-61
[30.]
S.R. Rapp, C.A. Cottrell, M.R. Leary.
Social coping strategies associated with quality of life decrements among psoriasis patients.
Br J Dermatol, 145 (2001), pp. 610-616
[31.]
F. Hassanyeh, D. Eccleston, K. Davison.
Rating of anxiety, depression and vulnerability.
Acta Psychiat Scand, 64 (1981), pp. 301-313
[32.]
M.M. Polenghi, E. Molinari, C. Gala, R. Guzzi, C. Garulti, A.F. Finzi.
Experience with psoriasis in a psychosomatic dermatologyclinic.
Acta Derm Venerol, 186 (1994), pp. 65-66
[33.]
E. Panconesi, G. Hautmann.
Psychophysiology of stress in dermatology.
Dermatol Clin, 14 (1996), pp. 399-422
[34.]
J. Shanon.
Psoriasis: psychosomatic aspects.
Psychoter Psychosom, 31 (1977), pp. 218-222
[35.]
M.A. Gupta, N.I. Schork, A.K. Gupta, S. Kirkby, C.N. Ellis.
Suicidal ideation in psoriasis.
lnt Dermatol, 32 (1993), pp. 188-190
[36.]
L. Ginsburg.
The psychosocial impact of skin disease.
Dermatol Clin, 14 (1996), pp. 473-482
[37.]
H. Devrimci-Ozguven, T.N. Kundakci, H. Kumbasar, A. Bowat.
The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients.
Europ Acad Dermatol Venereol, 14 (2000), pp. 267-271
[38.]
R.K. Roenigk, H.H. Roenigk Jr.
Sex differences in the psychosocial affects of psoriasis.
Cutis, 21 (1978), pp. 529-533
[39.]
M. Birkauser.
Depression, menopause and estrogens, is there a correlation?.
Maturitas, 1 (2002), pp. 53-58
[40.]
K. Gutiérrez-Lobos, M. Scherer, P. Anderer, H. Katschnig.
The influence of age on the female/male ratio of treated incidence rates in depression.
BMC Psychiatry, 2 (2002), pp. 3
[41.]
N. Lin, W.M. Ensel.
Depression-morbility and its social etiology: The role of life event and social support.
J Health Soc Behav, 25 (1984), pp. 176-188
[42.]
D. Dooley, J. Fielding, L. Levi.
Health and unemployment.
Annu Rev Public Health, 17 (1996), pp. 449-465
[43.]
R.C. Kessler, J.S. House, J. Turner.
Unemployment and Health in a Community Sample.
J Health Soc Behav, 28 (1987), pp. 51-59
[44.]
A. Picardi, E. Mazzotti, P. Pasquini.
Prevalence and correlates of suicidal ideation among patients with skin disease.
J Am Acad Dermatol, 54 (2006), pp. 420-426
Copyright © 2010. Academia Española de Dermatología y Venereología
